The Oncology Institute, Inc. (TOI): Price and Financial Metrics

The Oncology Institute, Inc. (TOI): $1.30

0.09 (-6.47%)

POWR Rating

Component Grades








Add TOI to Watchlist
Sign Up

Industry: Medical - Services




#56 of 65

in industry

TOI Price/Volume Stats

Current price $1.30 52-week high $2.66
Prev. close $1.39 52-week low $0.33
Day low $1.27 Volume 690,100
Day high $1.43 Avg. volume 392,033
50-day MA $1.77 Dividend yield N/A
200-day MA $1.05 Market Cap 95.87M

TOI Stock Price Chart Interactive Chart >


  • TOI scores best on the Sentiment dimension, with a Sentiment rank ahead of 86.59% of US stocks.
  • TOI's strongest trending metric is Momentum; it's been moving up over the last 154 days.
  • TOI's current lowest rank is in the Quality metric (where it is better than 8.35% of US stocks).

TOI Stock Summary

  • With a one year PEG ratio of 0.01, ONCOLOGY INSTITUTE INC is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than just 0.22% of US stocks.
  • In terms of twelve month growth in earnings before interest and taxes, ONCOLOGY INSTITUTE INC is reporting a growth rate of -18,587.71%; that's higher than just 0.15% of US stocks.
  • The volatility of ONCOLOGY INSTITUTE INC's share price is greater than that of 94.21% US stocks with at least 200 days of trading history.
  • Stocks with similar financial metrics, market capitalization, and price volatility to ONCOLOGY INSTITUTE INC are HCDI, GGE, RAND, WYNN, and XPOF.
  • To check out ONCOLOGY INSTITUTE INC's SEC filings, go to the company's page on browse-edgar?action=getcompany&CIK=0001799191.

TOI Valuation Summary

  • TOI's EV/EBIT ratio is -3.9; this is 130.71% lower than that of the median Healthcare stock.
  • TOI's price/sales ratio has moved down 1.4 over the prior 45 months.

Below are key valuation metrics over time for TOI.

Stock Date P/S P/B P/E EV/EBIT
TOI 2023-11-20 0.5 2.3 -2.2 -3.9
TOI 2023-11-17 0.5 2.4 -2.3 -4.0
TOI 2023-11-16 0.5 2.1 -2.0 -3.7
TOI 2023-11-15 0.5 2.3 -2.2 -3.9
TOI 2023-11-14 0.6 2.5 -2.4 -4.1
TOI 2023-11-13 0.6 2.6 -2.5 -4.3

The Oncology Institute, Inc. (TOI) Company Bio

The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, outpatient stem cell transplants and transfusions programs, and 24/7 patient support. The company was founded in 2007 and is headquartered in Cerritos, California.

TOI Latest News Stream

Event/Time News Detail
Loading, please wait...

TOI Latest Social Stream

Loading social stream, please wait...

View Full TOI Social Stream

Latest TOI News From Around the Web

Below are the latest news stories about ONCOLOGY INSTITUTE INC that investors may wish to consider to help them evaluate TOI as an investment opportunity.

The Oncology Institute Expands its Specialty Medication Business by Opening Pharmacy Operations in California

CERRITOS, Calif, Dec. 04, 2023 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (TOI) announced today that it has started operations of its first pharmacy in California after receiving approval from the California State Board of Pharmacy. This new service allows TOI to fill not only critical specialty medications and chemotherapeutics for MediCal patients, but also to provide medication fill capabilities to other patient populations. Located in the Los Angeles area, this new pharmacy location co

Yahoo | December 4, 2023

Insider Sell Alert: Director Brad Hively Sells 47,000 Shares of The Oncology Institute Inc (TOI)

In a notable insider transaction, Director Brad Hively has parted with 47,000 shares of The Oncology Institute Inc (NASDAQ:TOI), a significant move that warrants a closer look by investors and market analysts.

Yahoo | November 16, 2023

Even With A 49% Surge, Cautious Investors Are Not Rewarding The Oncology Institute, Inc.'s (NASDAQ:TOI) Performance Completely

Despite an already strong run, The Oncology Institute, Inc. ( NASDAQ:TOI ) shares have been powering on, with a gain of...

Yahoo | November 10, 2023

The Oncology Institute Inc (TOI) Reports Q3 2023 Results: Revenue Up, Net Loss Widens

TOI Reaffirms Full Year 2023 Guidance Amidst Expansion and Operational Developments

Yahoo | November 8, 2023

The Oncology Institute Reports Third Quarter 2023 Financial Results and Reaffirms Full Year 2023 Guidance

CERRITOS, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its three and nine months ended September 30, 2023 and reaffirmed its full year 2023 guidance. Recent Operational Highlights: Opened our 70th clinic and added 5 physicians bringing our total provider count to 112We are live on Ambience, a tool that utilizes AI te

Yahoo | November 8, 2023

Read More 'TOI' Stories Here

TOI Price Returns

1-mo -29.35%
3-mo 2.36%
6-mo 109.68%
1-year 13.04%
3-year -87.48%
5-year N/A
YTD -21.21%
2022 -83.08%
2021 -9.72%
2020 N/A
2019 N/A
2018 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!